Our Mission Our Mission

Our Mission

Empowering
precision medicine
at the local level.

Learn More

A Revolution in Molecular Profiling

Our next-generation sequencing (NGS)-adapted chemistry and instrument platforms automate sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets from samples a fraction of the size required by competitive technologies, enabling customers to do more molecular profiling with less sample.

Learn More

HTG EdgeSeq PATH Assay 

Compliment your immunohistochemistry with HTG's sequencing-based assay for mRNA gene expression. With just one formalin-fixed, paraffin-embedded (FFPE) slide, measure the mRNA expression of 470 biomarkers.

Get It Now

News & Events

HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018

TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that its senior management team will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place in San Francisco, January 8-10, 2018.

Category: Press Releases
Topics: HTG
Posted on:

Keep Reading

HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings

TUCSON, Ariz., Nov. 07, 2017 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today reported strengthening financial results for the three and nine month periods ended September 30, 2017.

Category: Press Releases
Topics: HTG, Reports
Posted on:

Keep Reading

HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7

TUCSON, Ariz., Oct. 20, 2017 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that it will report its financial results for the three and nine months ended September 30, 2017 after the market close on Tuesday, November 7th. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Category: Press Releases
Topics: HTG, Reports
Posted on:

Keep Reading

HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference

TUCSON, Ariz., Sept. 25, 2017 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced its management will present a corporate overview at the Cantor Fitzgerald Global Healthcare Conference in New York City on Monday, September 25 at 9:45am Eastern Time.

Category: Press Releases
Topics: HTG, Presentation
Posted on:

Keep Reading

Resources

Find product information, specifications and gene lists here. 

Brochures

Gene Lists

Product Sheets

Safety Data Sheets

Videos


Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars


Support

Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or assays. 

User Manuals RUO

User Manuals CE-IVD

Package Inserts RUO

Package Inserts CE-IVD

Training Modules RUO

Training Modules CE-IVD

Page last updated December 20, 2017

Ready to get started?

HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.

Get in Touch